This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hung, J. Articles by Levine, R. A. Search for Related Content PubMed PubMed Citation Articles by Hung, J. Articles by Levine, R. A. Related Collections Animal models of human disease CV surgery: valvular disease Chronic ischemic heart disease

(Circulation. 2007;116:I-259 – I-263.)
© 2007 American Heart Association, Inc.

Surgery for Valvular Heart Disease

Persistent Reduction of Ischemic Mitral Regurgitation by Papillary Muscle Repositioning

Structural Stabilization of the Papillary Muscle–Ventricular Wall Complex

Judy Hung, MD; Miguel Chaput, MD; J. Luis Guerrero, BS; Mark D. Handschumacher, BS; Lampros Papakostas, MD; Suzanne Sullivan, BS; Jorge Solis, MD; Robert A. Levine, MD

From the Cardiac Ultrasound Laboratory and Division of Cardiothoracic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Judy Hung, MD, Massachusetts General Hospital, Cardiac Ultrasound Laboratory, Blake 256, 55 Fruit Street, Boston, MA 02114. E-mail jhung{at}partners.org

Background— Recurrent ischemic mitral regurgitation (IMR) is frequent despite initial reduction by annuloplasty because continued LV remodeling increases tethering to the infarcted papillary muscle (PM). We have previously shown that PM repositioning by an external patch device can acutely reduce IMR. In this study, we tested the hypothesis that IMR reduction persists despite possible continued LV remodeling.

Methods and Results— In 7 sheep, we used a chronic ischemic posterior infarct model that produces LV dilatation and MR over 10 weeks. An epicardial patch device was adjusted under echo guidance to reduce MR, with follow-up over a further 8 weeks and evaluation by 3D echo and sonomicrometry. In all 7 sheep, moderate IMR resolved with acute patch application and PM repositioning (6.5±1.8 mm to 0.6±1.3 mm proximal jet width, P<0.001) without decrease in LVEF (43±3% to 44±8%). Eight weeks after PM repositioning, MR was not significantly greater (0.6±1.3 mm versus 1.0±1.0 mm, P=NS) despite an increase in LV volumes in 3 animals (2 had increases of 50±15%). On average, LV volumes did not change significantly (ESV: 46±8 mL versus 49±15 mL; P=NS and EDV: 85±16 mL versus 89±30 mL; P=NS). LVEF was unchanged from acute to chronic patch (44±8% versus 43±8%). Contractility as end-systolic elastance did not decrease from the chronic MI to the acute and chronic patch stages, nor were there any significant changes in dP/dt, LV stiffness constant, or time constant of LV relaxation (Tau).

Conclusion— PM repositioning is persistently effective in reducing moderate chronic IMR, even when LV volume increases. This may reflect structural stabilization by an external patch device of the papillary muscle-LV wall complex that controls mitral valve tethering.

Key Words: mitral regurgitation • left ventricular remodeling

This article has been cited by other articles:

				M. Chaput, M. D. Handschumacher, J. L. Guerrero, G. Holmvang, J. P. Dal-Bianco, S. Sullivan, G. J. Vlahakes, J. Hung, R. A. Levine, and for the Leducq Foundation MITRAL Transatlantic Net Mitral Leaflet Adaptation to Ventricular Remodeling: Prospective Changes in a Model of Ischemic Mitral Regurgitation Circulation, September 15, 2009; 120(11_suppl_1): S99 - S103. [Abstract] [Full Text] [PDF]